Skip to main content


Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

Fig. 1

The effects of dapagliflozin on body weight and fasting (6 h) blood glucose. a Changes in body weight from weeks 0 to 8; b 6 h fasted blood glucose levels from 0 to 8 weeks. Data are expressed as mean ± SEM; *p < 0.05 vs all other groups at the same time point; +p<0.05 vs both Con groups at same time point; #p < 0.05 from week 0 within the same treatment group; n = 11–12/group

Back to article page